NCT02138097View on ClinicalTrials.gov

Oral and Non-insulin Injected Hypoglycemic Therapy Utilization Patterns

CompletedOBSERVATIONAL
Enrollment

615,067

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

July 31, 2014

Study Completion Date

August 31, 2014

Conditions
Diabetes Mellitus, Type 2
Trial Locations (1)

Unknown

1218.161.1 Boehringer Ingelheim Investigational Site, Boston

Sponsors
All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

Boehringer Ingelheim

INDUSTRY

NCT02138097 - Oral and Non-insulin Injected Hypoglycemic Therapy Utilization Patterns | Biotech Hunter | Biotech Hunter